Non-engraftment donor leukocyte infusions
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Non-engraftment donor leukocyte infusions, covering 2026-07-23 to 2026-07-23. Get the full timeline:
Most recent: Clinical Trial Results: Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]